Sooch Mina 4
4 · Ocuphire Pharma, Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
Sooch Mina
DirectorPresident and CEO
Transactions
- Exercise of In-Money
Common Stock
2022-09-06$0.00/sh+1,023$0→ 426,045 total - Exercise of In-Money
Series B Warrant (right to buy)
2022-09-06−1,023→ 0 totalExercise: $0.00From: 2020-11-19Exp: 2022-09-07→ Common Stock (1,023 underlying)
Footnotes (1)
- [F1]The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrant has been exercised in full.